298 related articles for article (PubMed ID: 12042886)
1. Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
Misselwitz J; Franke S; Kauf E; John U; Stein G
Pediatr Nephrol; 2002 May; 17(5):316-21. PubMed ID: 12042886
[TBL] [Abstract][Full Text] [Related]
2. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
[TBL] [Abstract][Full Text] [Related]
3. Are advanced glycation end products cardiovascular risk factors in patients with CRF?
Stein G; Busch M; Müller A; Wendt T; Franke C; Niwa T; Franke S
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S52-6. PubMed ID: 12612953
[TBL] [Abstract][Full Text] [Related]
4. Improvement of the quality of diabetes control and decrease in the concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus: results from a 10 year-prospective, population-based survey on the quality of diabetes care in Germany (JEVIN).
Schiel R; Franke S; Appel T; Voigt U; Ross IS; Kientsch-Engel R; Müller UA; Stein G
Eur J Med Res; 2004 Aug; 9(8):391-9. PubMed ID: 15337629
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
Busch M; Franke S; Wolf G; Rohde RD; Stein G;
Nephron Clin Pract; 2008; 108(4):c291-7. PubMed ID: 18434751
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
[TBL] [Abstract][Full Text] [Related]
7. The advanced glycation endproduct pentosidine and monocyte activation in uremia.
Friedlander MA; Witko-Sarsat V; Nguyen AT; Wu YC; Labrunte M; Verger C; Jungers P; Descamps-Latscha B
Clin Nephrol; 1996 Jun; 45(6):379-82. PubMed ID: 8793229
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.
Hein G; Wiegand R; Lehmann G; Stein G; Franke S
Rheumatology (Oxford); 2003 Oct; 42(10):1242-6. PubMed ID: 12777635
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of advanced glycation end products in children with renal disease.
Sebeková K; Podracká L; Blazícek P; Syrová D; Heidland A; Schinzel R
Pediatr Nephrol; 2001 Dec; 16(12):1105-12. PubMed ID: 11793110
[TBL] [Abstract][Full Text] [Related]
10. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
Sebeková K; Podracká L; Heidland A; Schinzel R
Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
[TBL] [Abstract][Full Text] [Related]
11. Pentosidine and its deposition in renal tissue in renal transplantation.
Yoshida K; Yoneda T; Fujimoto K; Hirao Y; Konishi N
Transplant Proc; 2005 Dec; 37(10):4266-72. PubMed ID: 16387094
[TBL] [Abstract][Full Text] [Related]
12. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
[TBL] [Abstract][Full Text] [Related]
13. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
[TBL] [Abstract][Full Text] [Related]
14. Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine.
Uchimura T; Motomiya Y; Okamura H; Hashiguchi T; Miura M; Uji Y; Iwamoto H; Maruyama I
Nephron; 2002 Apr; 90(4):401-7. PubMed ID: 11961398
[TBL] [Abstract][Full Text] [Related]
15. Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis.
Odetti P; Monacelli F; Storace D; Robaudo C; Rossi S; Deferrari G; Barreca T
Horm Metab Res; 2006 Dec; 38(12):817-20. PubMed ID: 17163357
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
[TBL] [Abstract][Full Text] [Related]
17. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
Kerkeni M; Saïdi A; Bouzidi H; Ben Yahya S; Hammami M
Microvasc Res; 2012 Nov; 84(3):378-83. PubMed ID: 22835520
[TBL] [Abstract][Full Text] [Related]
19. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
Franke S; Müller A; Sommer M; Busch M; Kientsch-Engel R; Stein G
Clin Nephrol; 2003 Feb; 59(2):88-97. PubMed ID: 12608551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
